Early Cardiovascular Risk Assessment of Patients With COPD During Respiratory Exacerbation for the Identification and Treatment of Cardiovascular Comorbidity

What this Trial Is About

This research aims to evaluate patients hospitalized for COPD flare-ups by comparing two different care approaches. Patients will be randomly assigned to either see only a lung doctor (pulmonologist) or to see both a lung doctor and a heart doctor (cardiologist) during their hospital stay. The study focuses on identifying and managing heart problems that might affect people with COPD, with the goal of improving diagnosis and health outcomes over one year. During hospitalization, all patients will complete a questionnaire. The pulmonologist will review lung disease, adjust treatment, and recommend follow-up care. Those in the intervention group will also be evaluated by a cardiologist, who will assess heart-related conditions such as high cholesterol, diabetes, heart disease, high blood pressure, and heart failure. The cardiologist may start or adjust heart treatments based on this evaluation. Participants will be followed up by phone at 1, 3, 6, and 12 months after hospital discharge. These calls will check for any changes in treatment, new heart problems, COPD flare-ups, or death. Researchers will measure changes in cardiovascular treatment within six months and track new heart disease diagnoses, adverse events, and COPD exacerbations during the study period.

Cardiovascular Assessment and Treatment During COPD Exacerbation to Improve Diagnosis and Outcomes